GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (NAS:HBIO) » Definitions » Shiller PE Ratio

Harvard Bioscience (Harvard Bioscience) Shiller PE Ratio : (As of May. 11, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Harvard Bioscience Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Harvard Bioscience Shiller PE Ratio Historical Data

The historical data trend for Harvard Bioscience's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Bioscience Shiller PE Ratio Chart

Harvard Bioscience Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Harvard Bioscience Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Harvard Bioscience's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, Harvard Bioscience's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harvard Bioscience's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Harvard Bioscience's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Harvard Bioscience's Shiller PE Ratio falls into.



Harvard Bioscience Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Harvard Bioscience's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Harvard Bioscience's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.11/129.4194*129.4194
=-0.110

Current CPI (Mar. 2024) = 129.4194.

Harvard Bioscience Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.030 100.560 0.039
201409 0.020 100.428 0.026
201412 -0.001 99.070 -0.001
201503 -0.040 99.621 -0.052
201506 0.010 100.684 0.013
201509 -0.020 100.392 -0.026
201512 -0.510 99.792 -0.661
201603 -0.020 100.470 -0.026
201606 -0.020 101.688 -0.025
201609 -0.050 101.861 -0.064
201612 -0.040 101.863 -0.051
201703 -0.030 102.862 -0.038
201706 -0.010 103.349 -0.013
201709 -0.010 104.136 -0.012
201712 0.030 104.011 0.037
201803 -0.110 105.290 -0.135
201806 -0.040 106.317 -0.049
201809 -0.010 106.507 -0.012
201812 0.060 105.998 0.073
201903 -0.060 107.251 -0.072
201906 -0.010 108.070 -0.012
201909 -0.070 108.329 -0.084
201912 -0.120 108.420 -0.143
202003 -0.120 108.902 -0.143
202006 -0.040 108.767 -0.048
202009 -0.030 109.815 -0.035
202012 -0.020 109.897 -0.024
202103 -0.020 111.754 -0.023
202106 -0.010 114.631 -0.011
202109 -0.004 115.734 -0.004
202112 0.020 117.630 0.022
202203 -0.170 121.301 -0.181
202206 0.060 125.017 0.062
202209 -0.080 125.227 -0.083
202212 -0.040 125.222 -0.041
202303 0.010 127.348 0.010
202306 -0.020 128.729 -0.020
202309 -0.030 129.860 -0.030
202312 -0.040 129.419 -0.040
202403 -0.110 129.419 -0.110

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Harvard Bioscience  (NAS:HBIO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Harvard Bioscience Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Harvard Bioscience's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Harvard Bioscience (Harvard Bioscience) Business Description

Traded in Other Exchanges
Address
84 October Hill Road, Holliston, MA, USA, 01746
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
Executives
James W Green director, officer: Chief Executive Officer 12525 CHADRON AVENUE, HAWTHORNE CA 90250
Alan I Edrick director 20200 SUNBURST STREET, CHATSWORTH CA 91311
Jennifer Cote officer: Interim CFO C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Bertrand Loy director C/O ENTEGRIS, INC., 129 CONCORD RD, BILLERICA MA 01821
Thomas W Loewald director 81 WYMAN STREET, WALTHAM MA 02451
John F Kennedy director C/O NET PERCEPTIONS INC, 7700 FRANCE AVE. SOUTH, EDINA MN 55435
Katherine A. Eade director C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Susan M. Steele director C/O HILL INTERNATIONAL, INC., 2005 MARKET ST., 17TH FLOOR, PHILADELPHIA PA 19103
Kenneth Fletcher Olson officer: Chief Operating Officer C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Michael A. Rossi officer: Chief Financial Officer C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Yash Singh officer: Executive Vice President C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Jeffrey Duchemin officer: Chief Executive Officer 14 EASTLAND TERRACE, HAVERHILL MA 01830
Kamalam Unninayar officer: Chief Financial Officer C/O TETRAPHASE PHARMACEUTICALS, INC., 480 ARSENAL STREET, SUITE 110, WATERTOWN MA 02472
Robert E. Gagnon officer: Chief Financial Officer C/O BIOGEN IDEC INC., 133 BOSTON POST ROAD, WESTON MA 02493
George Uveges director C/O MFIC CORPORATION, 30 OSSIPEE ROAD, NEWTON MA 02464

Harvard Bioscience (Harvard Bioscience) Headlines